Douglas Dong Fang

Person

Suzhou, CN

People

Patents Grantslast 30 patents

Information Patent Grant
Combination of BCL-2/BCL-XL inhibitors and chemotherapeutic agent a...
- Patent number 12,083,136
- Issue date Sep 10, 2024
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun Yang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination product of BCL-2 inhibitor and MDM2 inhibitor and use t...
- Patent number 11,478,469
- Issue date Oct 25, 2022
- ASCENTAGE PHARMA (SUZHOU) CO., LTD.
- Dajun Yang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination product of Bcl-2 inhibitor or Bcl-2/Bcl-xL dual inhibit...
- Patent number 11,478,470
- Issue date Oct 25, 2022
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun Yang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treating cancer by combination of FAK/ALK/ROS1 inhibitor...
- Patent number 11,478,477
- Issue date Oct 25, 2022
- ASCENTAGE PHARMA (SUZHOU) CO., LTD.
- Dajun Yang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical composition and use thereof
- Patent number 11,452,716
- Issue date Sep 27, 2022
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun Yang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compound for treating osteoarthritis
- Patent number 11,395,815
- Issue date Jul 26, 2022
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun Yang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
A PHARMACEUTICAL COMBINATION AND USE THEREOF
- Publication number 20240316051
- Publication date Sep 26, 2024
- Ascentage Pharma (Suzhou) Co., Ltd.
- Yifan ZHAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING MULTIPLE SCLEROSIS
- Publication number 20240316069
- Publication date Sep 26, 2024
- Ascentage Pharma (Suzhou) Co., Ltd.
- Saijie ZHU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS
- Publication number 20230398110
- Publication date Dec 14, 2023
- Ascentage Pharma (Suzhou) Co., Ltd.
- Yifan ZHAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A PHARMACEUTICAL COMPOSITION AND USE THEREOF FOR TREATMENT OF CANCER
- Publication number 20230381176
- Publication date Nov 30, 2023
- Ascentage Pharma (Suzhou) Co., Ltd.
- Yifan Zhai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MICROSUSPENSION OF AN MDM2 INHIBITOR AND THERAPEAUTIC APPLICATIONS...
- Publication number 20230218575
- Publication date Jul 13, 2023
- Ascentage Pharma (Suzhou) Co., Ltd.
- Saijie Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for Treating Coronavirus Infections
- Publication number 20230078120
- Publication date Mar 16, 2023
- ASCENTAGE PHARMA (SUZHOU) CO.,LTD.
- Yifan Zhai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF IAP INHIBITORS AND PARP OR MEK INHIBITORS OR OTHER C...
- Publication number 20230029259
- Publication date Jan 26, 2023
- Ascentage Pharma (Suzhou) Co., Ltd.
- Yifan Zhai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATION AND USE THEREOF
- Publication number 20220323465
- Publication date Oct 13, 2022
- Ascentage Pharma (Suzhou) Co., Ltd.
- Yifan ZHAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD AND COMPOSITIONS FOR PREDICTING ANTI-CANCER EFFICACY OF COMP...
- Publication number 20220317127
- Publication date Oct 6, 2022
- Ascentage Pharma (Suzhou) Co., Ltd.
- Yifan ZHAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD AND COMPOSITION FOR PREDICTING EFFICACY OF BCL2/BCL-XL INHIB...
- Publication number 20220233558
- Publication date Jul 28, 2022
- Ascentage Pharma (Suzhou) Co., Ltd.
- Yifan ZHAI
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION OF IMMUNOTHERAPIES WITH MDM2 INHIBITORS
- Publication number 20220175725
- Publication date Jun 9, 2022
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun YANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITION OF MDM2 INHIBITOR AND USE THEREOF FOR PR...
- Publication number 20220142979
- Publication date May 12, 2022
- Dajun YANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION PRODUCT OF A BCL-2/BCL-XL INHIBITOR AND A CHEMOTHERAPEU...
- Publication number 20220143039
- Publication date May 12, 2022
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun Yang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Combination and Use Thereof
- Publication number 20220142975
- Publication date May 12, 2022
- Ascentage Pharma (Suzhou) Co., Ltd.
- Yifan Zhai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION PRODUCT OF BCL-2 INHIBITOR AND MDM2 INHIBITOR AND USE T...
- Publication number 20220031694
- Publication date Feb 3, 2022
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun YANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR TREATING CANCER BY COMBINATION OF IAP INHIBITOR AND MODU...
- Publication number 20210330642
- Publication date Oct 28, 2021
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun YANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR TREATING CANCER BY COMBINATION OF FAK/ALK/ROSI INHIBITOR...
- Publication number 20210330669
- Publication date Oct 28, 2021
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun YANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT METHODS AND BIOMARKERS FOR MDM2 INHIBITORS
- Publication number 20210311020
- Publication date Oct 7, 2021
- Ascentage Pharma (Suzhou) Co., Ltd.
- Yifan ZHAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS AND USE THEREOF
- Publication number 20210275522
- Publication date Sep 9, 2021
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun YANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF BCL-2/BCL-XL INHIBITORS AND CHEMOTHERAPEUTIC AGENT A...
- Publication number 20210060039
- Publication date Mar 4, 2021
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun YANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL PHARMACEUTICAL COMPOSITION AND USE THEREOF
- Publication number 20200297704
- Publication date Sep 24, 2020
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun Yang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION PRODUCT OF BCL-2 INHIBITOR OR BCL-2/BCL-XL DUAL INHIBIT...
- Publication number 20200222393
- Publication date Jul 16, 2020
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun YANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUND FOR TREATING OSTEOARTHRITIS
- Publication number 20200222366
- Publication date Jul 16, 2020
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun Yang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Douglas Dong Fang

Person

Patents Grantslast 30 patents

Combination of BCL-2/BCL-XL inhibitors and chemotherapeutic agent a...

Combination product of BCL-2 inhibitor and MDM2 inhibitor and use t...

Combination product of Bcl-2 inhibitor or Bcl-2/Bcl-xL dual inhibit...

Method for treating cancer by combination of FAK/ALK/ROS1 inhibitor...

Pharmaceutical composition and use thereof

Compound for treating osteoarthritis

Patents Applicationslast 30 patents

A PHARMACEUTICAL COMBINATION AND USE THEREOF

METHODS OF TREATING MULTIPLE SCLEROSIS

COMPOSITIONS AND METHODS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS

A PHARMACEUTICAL COMPOSITION AND USE THEREOF FOR TREATMENT OF CANCER

MICROSUSPENSION OF AN MDM2 INHIBITOR AND THERAPEAUTIC APPLICATIONS...

Methods for Treating Coronavirus Infections

COMBINATION OF IAP INHIBITORS AND PARP OR MEK INHIBITORS OR OTHER C...

PHARMACEUTICAL COMBINATION AND USE THEREOF

METHOD AND COMPOSITIONS FOR PREDICTING ANTI-CANCER EFFICACY OF COMP...

METHOD AND COMPOSITION FOR PREDICTING EFFICACY OF BCL2/BCL-XL INHIB...

COMBINATION OF IMMUNOTHERAPIES WITH MDM2 INHIBITORS

PHARMACEUTICAL COMPOSITION OF MDM2 INHIBITOR AND USE THEREOF FOR PR...

COMBINATION PRODUCT OF A BCL-2/BCL-XL INHIBITOR AND A CHEMOTHERAPEU...

Pharmaceutical Combination and Use Thereof

COMBINATION PRODUCT OF BCL-2 INHIBITOR AND MDM2 INHIBITOR AND USE T...

METHOD FOR TREATING CANCER BY COMBINATION OF IAP INHIBITOR AND MODU...

METHOD FOR TREATING CANCER BY COMBINATION OF FAK/ALK/ROSI INHIBITOR...

TREATMENT METHODS AND BIOMARKERS FOR MDM2 INHIBITORS

PHARMACEUTICAL COMPOSITIONS AND USE THEREOF

COMBINATION OF BCL-2/BCL-XL INHIBITORS AND CHEMOTHERAPEUTIC AGENT A...

NOVEL PHARMACEUTICAL COMPOSITION AND USE THEREOF

COMBINATION PRODUCT OF BCL-2 INHIBITOR OR BCL-2/BCL-XL DUAL INHIBIT...

COMPOUND FOR TREATING OSTEOARTHRITIS